Home blAST About Us Resources Contact

What is blAST?

blAST is a Bio-Labeled Antimicrobial Susceptibility Test (AST) that uses award-winning click chemistry to analyze antimicrobial sensitivity directly from urine samples.

Can AST be done in less
than 24 hours?

blAST is a direct urine phenotypic AST that provides single-shift results in ~6 hours.

blAST bypasses the need for a growth phase and eliminates standard culture timelines. The simplified laboratory workflow provides actionable, accurate, and reliable AST results from metabolically-active pathogens.

96-well plate
blAST workflow timeline comparison: blAST Protocol ~6 hours vs Standard Culture 24-48+ hours

How does direct sample phenotypic AST work?

MRSA Bacteria

blAST provides phenotypic information:

  1. Protein synthesis reflects viability
    • Live pathogens synthesize protein
    • Dead or inhibited pathogens do not
  2. Antimicrobial activity suppresses protein synthesis
    • Effective therapy reduces metabolic activity
    • Resistance preserves it
  3. Bio-labeling measures protein synthesis directly
    • Click chemistry tags newly synthesized proteins
    • Signal suppression defines susceptibility
    • Same-shift phenotypic MIC
    • No microbe replication required

blAST uses an organism's own protein metabolism to create a fluorescent signal from pathogens that are still viable after being treated with antimicrobial agents. This signal can be measured on a fluorescent plate reader and used to calculate MIC.

Can you use direct phenotypic AST for infections like cUTI?

blAST provides personalized results at the time of infection, eliminating culture bias and treatment delays from standard culture and isolation methods.

Targeted and Effective

Precisely identifies the most effective antimicrobial reducing trial and error.

User-Friendly

Straight forward, non-invasive testing for patients and providers.

Reduces Recurrence

Starting the right antimicrobial early, lowers the risk of infection return.

Eliminates Culture

No bias from monomicrobial growth or culture conditions.

Follow-up Testing

Enables ongoing adjustment of treatments for optimal outcomes.

Quick Decisions

Delivers results in ~6 hours, expediting treatment initiation.

Safety

Minimizes unnecessary antimicrobial exposure and potential side effects.

Global Application

Aids in the battle against resistance by promoting appropriate antimicrobials.

Comparative Advantage

CytoSPAR BLAST Industry Standard
Tests Direct from Urine Sample
Bypasses Growth Phase for Analysis
Determines MIC
Direct Result Delivery to Provider
Results in ~6 hours
Objective Results
Works on both Gram-positive and Gram-negative bacteria